Definitive Contract HHSN261200533001C
Award Date 8/30/05
Potential Completion Date 8/31/12
Potential Value $20M
Federal Agency
Ultimate Awardee
Not listed NAICS Category
Not listed Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Cost No Fee
Place of Performance
Columbus, OH 43210, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
3
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a federal contract award issued by the National Cancer Institute (NCI), a civilian agency of the U.S. government, to The Ohio State University Research Foundation. The contract, valued at $20,352,600.57, is for early therapeutic development with a Phase II emphasis. It is a definitive contract with a cost-no-fee pricing type and has an ultimate completion date of October 31, 2012. The Ohio State University Research Foundation is a U.S. state government entity and 1862 Land Grant...
- This is a definitive, firm-fixed-price contract awarded by the Department of Health and Human Services Centers for Disease Control and Prevention (CDC) to The Ohio State University for the "OHIO STATE ORGANISMS & GENES STUDY." The contract, which does not have a set-aside designation, was awarded on September 30, 2018 with a potential value of $385,853.00 and a completion date of December 31, 2019. As a public research university, The Ohio State University has a history of...
- This is a $2,939.40 firm fixed-price delivery order contract awarded by the National Cancer Institute (NCI) to The Ohio State University. The contract supports the Cancer Genome Atlas (TCGA) program, which is funded by the American Recovery and Reinvestment Act (ARRA), to obtain tissue samples and data from various types of cancer. There is no set-aside designation. The Ohio State University is the prime contractor, and the contract has an ultimate completion date of September 30, 2014. This...
- The U.S. Department of Health and Human Services Centers for Disease Control and Prevention (CDC) awarded a definitive cost-no-fee contract valued at $693,598.00 to The Ohio State University (OSU) on September 29, 2017. The contract, which does not have a set-aside designation, is for unspecified "other functions" and is scheduled for completion on March 31, 2019. OSU, through its Office of Sponsored Programs, has previously provided various goods and services to federal agencies,...
- This federal contract award in the amount of $97,584.97 was issued by the Food and Drug Administration (FDA) to The Ohio State University. The award is part of the OARSA CONSORTIUM and has a period of performance ending on September 30, 2017. The contract is a firm fixed-price purchase order and does not have a set-aside designation. The Ohio State University has a history of providing various goods and services to federal agencies, including coordination and support services for clinical trials...
- The Ohio State University's Office of Sponsored Programs has been awarded a research grant valued at $139,780.49 by a civilian shared services center to execute a balanced science program aligned with discipline-specific guidance from the National Academies of Sciences, Engineering, and Medicine, administration priorities, and Congressional direction. The grant, designated as a child contract with no set-aside provisions, carries an ultimate completion date of January 26, 2027, and will be...
- The Department of Health and Human Services National Institutes of Health Clinical Center awarded a $20,000.00 firm fixed-price purchase order to The Ohio State University for a 2-day leading evidence-based practice workshop. The contract does not have a set-aside designation. The Ohio State University is a public research university that has previously provided various goods and services to federal agencies through prime contracts and subcontracts, including coordination and support services...
- This federal contract award is for $582,526.00 and was granted to The Ohio State University by the Shared Services Center, a civilian federal agency. The contract is for the university to execute a balanced science program based on guidance from the National Academies, administration priorities, and congressional direction. The scope includes participating as a key partner in the agency's exploration initiative, advancing discovery in emerging fields, and developing a target-user focused...
- This is a firm fixed-price purchase order contract awarded by the Department of Health and Human Services Food and Drug Administration to The Ohio State University on September 4, 2018 with a potential value of $158,623.00 and a completion date of November 30, 2019. The contract is for the "OSU CONSORTIUM FOR OARSA" and does not have a set-aside designation. As a public research university, The Ohio State University has a history of providing various goods and services to federal...
- The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a firm-fixed-price purchase order contract to The Ohio State University to obtain data on a group of proton-treated pediatric cancer patients and a comparison group of photon-treated pediatric cancer patients. The $243,347.00 contract has a completion date of September 14, 2023. The Ohio State University, a public research university, will retrieve existing medical record data on...